论文部分内容阅读
目的观察卡介菌多糖核酸联合阿维A治疗扁平疣的临床疗效。方法 60例患扁平疣患者,随机分成二组,治疗组30例,用卡介菌多糖核酸2 ml,隔日1次,肌内注射。阿维A胶囊10 mg,2次/d,口服。对照组30例,用聚肌胞2 ml,1次/d,肌内注射,阿昔洛韦200 mg,3次/d,口服。疗程均4周。结果治疗组痊愈22例,显效4例,好转2例,无效2例,治愈率73%,有效率86.7%。对照组痊愈15例,显效6例,好转6例,无效3例,痊愈率为50%,有效率为70%。结论治疗组与对照组治疗扁平疣差异有统计学意义(P<0.05),卡介菌多糖核酸与阿维A治疗扁平疣有较好的疗效。
Objective To observe the clinical efficacy of BCG polysaccharide nucleic acid combined with Avia A in the treatment of flat warts. Methods Sixty patients with flat warts were randomly divided into two groups. The treatment group consisted of 30 patients with 2 ml of BCG polysaccharide nucleic acid and intramuscular injection once every other day. Avi A capsule 10 mg, 2 times / d, orally. Control group of 30 cases, with polyarterial 2 ml, 1 / d, intramuscular injection of acyclovir 200 mg, 3 times / d, orally. Treatment are 4 weeks. Results The treatment group cured 22 cases, 4 cases markedly improved, 2 cases improved, 2 cases ineffective, the cure rate was 73%, the effective rate was 86.7%. The control group cured 15 cases, 6 cases markedly improved, 6 cases improved, 3 cases ineffective, the cure rate was 50%, the effective rate was 70%. Conclusion There is significant difference between the treatment group and the control group in the treatment of flat warts (P <0.05). The BCG-PSN has better efficacy in treating flat-faced warts.